{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Nerivio", "query": { "intervention": "Nerivio" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 25, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Nerivio&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-05T03:33:52.487Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07336056", "title": "Nerivio Efficacy Under High-Frequency Use", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "Nerivio (REN device)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Theranica", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": null, "sex": "ALL", "summary": "8 Years and older" }, "enrollment_count": 2000, "start_date": "2026-01-08", "completion_date": "2026-01-30", "has_results": false, "last_update_posted_date": "2026-01-13", "last_synced_at": "2026-09-05T03:33:52.487Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT07336056" }, { "nct_id": "NCT07487701", "title": "Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "Nerivio REN device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Theranica", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": null, "sex": "ALL", "summary": "8 Years and older" }, "enrollment_count": 332, "start_date": "2026-02-20", "completion_date": "2026-04-15", "has_results": false, "last_update_posted_date": "2026-07-01", "last_synced_at": "2026-09-05T03:33:52.487Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT07487701" }, { "nct_id": "NCT04828707", "title": "Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "Nerivio active device", "type": "DEVICE" }, { "name": "Nerivio sham device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Theranica", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 335, "start_date": "2021-04-13", "completion_date": "2022-10-10", "has_results": true, "last_update_posted_date": "2023-03-15", "last_synced_at": "2026-09-05T03:33:52.487Z", "location_count": 16, "location_summary": "Phoenix, Arizona • Carlsbad, California • Newport Beach, California + 13 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Carlsbad", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Boynton Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04828707" }, { "nct_id": "NCT05464069", "title": "Safety of Nerivio in Pregnant Women With Migraine", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Migraine", "Pregnancy Related" ], "interventions": [ { "name": "Nerivio", "type": "DEVICE" }, { "name": "Migraine Relief", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Theranica", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "42 Years", "sex": "FEMALE", "summary": "18 Years to 42 Years · Female only" }, "enrollment_count": 145, "start_date": "2022-08-01", "completion_date": "2022-12-07", "has_results": true, "last_update_posted_date": "2025-10-06", "last_synced_at": "2026-09-05T03:33:52.487Z", "location_count": 2, "location_summary": "San Diego, California • Montclair, New Jersey", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Montclair", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05464069" }, { "nct_id": "NCT05310227", "title": "Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "New Daily Persistent Headache (NDPH)" ], "interventions": [ { "name": "Nerivio", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Children's National Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 0, "start_date": "2022-02-01", "completion_date": "2023-09-11", "has_results": false, "last_update_posted_date": "2025-07-24", "last_synced_at": "2026-09-05T03:33:52.487Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05310227" }, { "nct_id": "NCT04992897", "title": "Real-world Data Analysis of REN Treatment in Migraine Patients", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Migraine" ], "interventions": [ { "name": "Remote Electrical Neuromodulation (REN)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Theranica", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 12151, "start_date": "2021-06-15", "completion_date": "2021-08-10", "has_results": false, "last_update_posted_date": "2024-11-22", "last_synced_at": "2026-09-05T03:33:52.487Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04992897" }, { "nct_id": "NCT07336420", "title": "Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Migraine", "Acute Treatment of Migraine" ], "interventions": [ { "name": "Nerivio REN device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Theranica", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 466, "start_date": "2026-01-09", "completion_date": "2026-01-30", "has_results": false, "last_update_posted_date": "2026-04-03", "last_synced_at": "2026-09-05T03:33:52.487Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT07336420" }, { "nct_id": "NCT04089761", "title": "Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Migraine" ], "interventions": [ { "name": "Nerivio", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Theranica", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 60, "start_date": "2019-10-01", "completion_date": "2020-05-24", "has_results": true, "last_update_posted_date": "2021-02-25", "last_synced_at": "2026-09-05T03:33:52.487Z", "location_count": 12, "location_summary": "Aurora, Colorado • Hialeah, Florida • Miami, Florida + 8 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04089761" }, { "nct_id": "NCT06738056", "title": "Nerivio Long-term Usage in Patients With Migraine", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Migraine", "Acute Treatment of Migraine" ], "interventions": [ { "name": "Nerivio", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Theranica", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 244, "start_date": "2024-12-01", "completion_date": "2024-12-22", "has_results": false, "last_update_posted_date": "2025-07-17", "last_synced_at": "2026-09-05T03:33:52.487Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT06738056" }, { "nct_id": "NCT05769322", "title": "Real World Data Analysis: Impact of High-Frequency REN Treatments As Migraine Preventive Therapy in Adolescence", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Migraine" ], "interventions": [ { "name": "Nerivio", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Theranica", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "12 Years to 18 Years" }, "enrollment_count": 83, "start_date": "2023-04-01", "completion_date": "2023-05-01", "has_results": false, "last_update_posted_date": "2024-11-22", "last_synced_at": "2026-09-05T03:33:52.487Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05769322" } ] }